Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?

Published:2021-06-08 Issue:10 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Maese Luke¹^ORCID,Rizzari Carmelo²,Coleman Russell³,Power Austin⁴,Sluis Inge⁵^ORCID,Rau Rachel E.⁶

Affiliation:

1. Huntsman Cancer Institute University of Utah Salt Lake City Utah USA

2. Pediatric Hematology‐Oncology Unit, Department of Pediatrics University of Milano‐Bicocca, MBBM Foundation Monza Italy

3. Ligand Biopharmaceuticals San Diego California USA

4. Jazz Pharmaceuticals Dublin Ireland

5. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

6. Baylor College of Medicine Texas Children's Cancer and Hematology Center Houston Texas USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29169

Reference47 articles.

1. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden

2. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

3. Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

4. Universal premedication and therapeutic drug monitoring for asparaginase‐based therapy prevents infusion‐associated acute adverse events and drug substitutions

5. L-asparaginase treatment in acute lymphoblastic leukemia

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive insight into exploring the potential of microbial enzymes in cancer therapy: Progress, challenges, and opportunities: A review;International Journal of Biological Macromolecules;2024-10

2. In Silico-Driven Engineering ofHalomonas elongataL-Asparaginase: Towards Enhanced Proteolytic Resistance in Lymphoblastic Leukemia;2024-06-08

3. Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial;Journal of Clinical Oncology;2024-05-10

4. Desirable L-asparaginases for treating cancer and current research trends;Frontiers in Microbiology;2024-03-13

5. l-Asparaginase from Solanum lycopersicum as a Nutraceutical for Acute Lymphoblastic Leukemia;ACS Omega;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3